In addition, the incidence of brain metastasis is higher in NSCLC patients with mutated EGFR than in NSCLC patients with wild-type EGFR, implying a correlation between EGFR mutation and brain metastasis (Ge et al., 2017). Here, EGFR is linked to non-small cell lung carcinoma.